Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-17

Clinical Trial Update: Minocycline to Treat Central Retinal Vein Occlusion [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating minocycline for central retinal vein occlusion (retinal vein occlusion).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Retinal Vein Occlusion | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-03-17